🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Udi E. Ghitza

National Institutes of Health

ORCID: 0000-0001-9964-8066

Also affiliated with National Institute on Drug Abuse

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
0.978Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study

Addiction(2022)10.1111/add.15875
Top 21%
0.978DataRank
Top 21%23 citations

John Marsden, Connor McCluskey, Randy A. Boley, Katharine A. Bradley, Cynthia I. Campbell +18 more

Papers

Driven by 19 papers — median percentile 79. Top paper: “The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study”.

The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study

Addiction(2022)10.1111/add.15875
Top 21%
0.978DataRank
Top 21%23 citations

John Marsden, Connor McCluskey, Randy A. Boley, Katharine A. Bradley, Cynthia I. Campbell +18 more

Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder

Addiction Science & Clinical Practice(2024)10.1186/s13722-024-00455-9
N/A
0.632DataRank · unranked
11 citations

P. Todd Korthuis, Julie M. Donohue, Hildi Hagedorn, Dave Gustafson, Angela R. Bazzi +10 more

Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test

Drug and Alcohol Dependence(2021)10.1016/j.drugalcdep.2021.109067
N/A
0.489DataRank · unranked
25 citations

Jennifer L. Brown, Ziji Yu, Stacey Frede, M. Aryana Bryan, Andrew Ferguson +8 more

An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches

Frontiers in Psychiatry(2021)10.3389/fpsyt.2021.674691
N/A
0.457DataRank · unranked
6 citations

Nithin Sugavanam, August F. Holtyn, Kenzie L. Preston, Jeremiah W. Bertz, Lisa A. Marsch +7 more

Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy

Substance Abuse(2023)10.1177/08897077231203849
N/A
0.416DataRank · unranked
15 citations

Jeffrey Bratberg, Anne Burns, Gerald Cochran, Bethany A. DiPaula, Anna Legreid Dopp +10 more

Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study

Journal of Pain(2022)10.1016/j.jpain.2022.03.238
N/A
0.315DataRank · unranked
4 citations

Akiko Okifuji, M. Aryana Bryan, Sarah E. Reese, Jennifer L. Brown, Andrew Ferguson +4 more

Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107148
N/A
0.216DataRank · unranked
3 citations

Matisyahu Shulman, Onumara Opara, Kenzie M. Potter, Delia Voronca, Hiwot M. Tafessu +12 more

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder

Addiction Science & Clinical Practice(2024)10.1186/s13722-024-00510-5
N/A
0.165DataRank · unranked
2 citations

Kelly S. Barth, Paulette Baukol, Eva A. Enns, Udi E. Ghitza, Jacklyn Harris +7 more

Outcomes From the Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2024.112242
N/A
0DataRank · unranked
0 citations

Udi E. Ghitza, Steven J. Nieto, Erik S. Anderson, Tara G. Chowdhury, Julie M. Croff +7 more

Anxiety Scores may Be Associated With Differences in Induction Onto Sublingual Buprenorphine Among Participants With Moderate/Severe Methamphetamine Use Disorder and Opioid Misuse

Drug and Alcohol Dependence(2025)10.1016/j.drugalcdep.2024.112091
N/A
0DataRank · unranked
0 citations

Madhukar H. Trivedi, Udi E. Ghitza, Erik S. Anderson, Tara G. Chowdhury, Julie M. Croff +7 more

The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network

Journal of Substance Abuse Treatment(2020)10.1016/j.jsat.2020.02.005
N/A
0DataRank · unranked
78 citations

Aimee Campbell, Cynthia I. Campbell, Ching-Hua Chen, Emre Ertin, Udi E. Ghitza +20 more

Research agenda evaluating measurement-based care for opioid use disorder among patients with co-occurring depressive disorders

Frontiers in Psychiatry(2025)10.3389/fpsyt.2025.1624642
N/A
0DataRank · unranked
0 citations

Udi E. Ghitza

Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network

Addiction(2021)10.1111/add.15353
N/A
0DataRank · unranked
54 citations

William S. John, Udi E. Ghitza, Aimee Wahle, Abigail G. Matthews, Mitra Lewis +7 more

Concomitant Cannabis Misuse and Associations with Depression, Pain and Substance Misuse among Patients Prescribed Opioids

Pharmacy(2021)10.3390/pharmacy9030134
N/A
0DataRank · unranked
1 citations

Elizabeth Charron, Omolola A. Adeoye‐Olatunde, Jennifer L. Brown, Udi E. Ghitza, Theresa Winhusen +2 more

Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study

Addiction Science & Clinical Practice(2022)10.1186/s13722-022-00318-1
N/A
0DataRank · unranked
11 citations

Sheila Markwardt, Kirbee Johnston, Jonah Geddes, Robin Baker, Gillian Leichtling +7 more

Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals

Journal of Substance Use and Addiction Treatment(2024)10.1016/j.josat.2024.209520
N/A
0DataRank · unranked
9 citations

Hildi Hagedorn, Honora Englander, Tracy Siegler, Roxanne Kibben, Adetayo Fawole +16 more

Hospital Provider’s Perspectives on MOUD Initiation and Continuation After Inpatient Discharge

Journal of General Internal Medicine(2024)10.1007/s11606-024-09008-x
N/A
0DataRank · unranked
6 citations

Honora Englander, Hildi Hagedorn, Adetayo Fawole, JoAn R. Laes, Hope Titus +16 more

Patient Characteristics of Fentanyl Positive Individuals With Opioid Use Disorder

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110398
N/A
0DataRank · unranked
0 citations

Mei‐Chen Hu, Matisyahu Shulman, Kathryn Hefner, Onumara Opara, Kenzie M. Potter +5 more

Delivering MOUD to the Underserved: How Can Pharmacies Really Help?

Journal of Studies on Alcohol and Drugs(2024)10.15288/jsad.24-00150
N/A
0DataRank · unranked
0 citations

Todd Molfenter, Thomas Kunes, Lisa Langdon, Michael Koplin, Francis Parker +4 more